Several classical and well-accepted prognostic factors have been reported in breast cancer, including tumor size, axillary lymph node (LN) status, histologic grade, hormone receptor status, HER2/neu status, and the presence of lymphovascular invasion (LVI) (1–5). This evidence concerns the gene ERBB2 and breast cancer.